PARP1 and glioblastoma: Therefore, combining the newly identified RECQ1-PARP1 signaling function in genome stability and clinical resistance of GBM cells, further studies to discover how these complexities can be resolved to promote fork restarting and progression and the possible synthetic interactions with other human helicases will provide new insights into the mechanism of GBM progression.